Unchained Labs biologics research tools available from AXT

AXT has partnered with the life sciences company Unchained Labs and will now be exclusively distributing its innovative and novel range of instruments for the analysis and formulation of biologics in Australia and New Zealand. The products will be of particular interest to researchers developing protein-based therapeutics that have the potential to treat a range of illnesses and diseases, including cancer.

Unchained Labs has developed a range of problem-solving products for biologics research and drug development. By taking existing technologies and adding improvements, their solutions have been designed to replace current methods and tools that may not be as efficient or productive. Their products are said to be characterised by increased capabilities, multifunctionality, automation and sensitivity, allowing users to spend less time developing and refining protein formulations.

Unchained Labs claims to make light work of analysing biologics — from protein sizing and prediction of aggregation and stability through to ramping up the preparation of biologic formulations. With the addition of the freeslate and freeslate jr. products, robust and sensitive automation of biologics formulations, small molecular preformulation and process chemistry becomes a simplified walkaway process.

“With the current global share of biologics-based drugs increasing, it is an exciting time for us to partner with a company producing such breakthrough and groundbreaking products,” said Desley Pitcher, national sales manager for life science at AXT.

“We look forward to putting these cutting-edge solutions in the hands of local researchers as they will help keep us at the forefront of medical research.”